- Janssen’s Cilta-Cel CAR T Receives FDA Approval for Relapsed Multiple Myeloma Myeloma Crowd News
- Johnson & Johnson, Legend’s CAR-T Carvykti enters myeloma ring with FDA nod FiercePharma
- ‘We are ready to go’: FDA OKs J&J and Legend’s BCMA CAR-T, setting stage for showdown with Bristol Myers Endpoints News
- CAR T-Cell Therapy Approved for Heavily Pretreated Multiple Myeloma Pharmacy Practice News
- View Full Coverage on Google News